Optiscan Imaging (OIL.AX) Akcie Kurz
Optiscan Imaging Kurz
Tržby Optiscan Imaging klesaly o 12,5 % ročně za posledních 19 let na 448 769,00 AUD. čistá marže společnosti Optiscan Imaging je nyní -1 556,7 %, dolů z -417,9 % před několika lety.
Cena akcie Optiscan Imaging
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model Optiscan Imaging a analýza akcií
Nejčastější otázky týkající se akcie Optiscan Imaging
The business model of Optiscan Imaging Ltd focuses on developing and commercializing advanced medical imaging technologies. The company specializes in the design and manufacture of confocal laser endomicroscopes, which are used in various medical applications. Optiscan Imaging aims to improve the diagnosis and treatment of diseases through their innovative imaging solutions. By leveraging their expertise in advanced imaging technologies, the company aims to provide healthcare professionals with high-quality and real-time cellular imaging during medical procedures. Optiscan Imaging Ltd's business model is centered around offering cutting-edge medical imaging technologies that deliver precise and detailed cellular imaging for improved patient outcomes.
Optiscan Imaging Ltd is primarily active in the medical technology and healthcare industries.
The main competitors of Optiscan Imaging Ltd in the market include companies such as Carl Zeiss Meditec AG, NIDEK CO., LTD., and Topcon Corporation.
Optiscan Imaging Ltd is a renowned company specializing in medical imaging technologies. Established in [year], Optiscan has achieved significant milestones in the field of diagnostic imaging. The company is known for its innovative optical imaging systems, such as confocal microscopy, which provide high-resolution cellular images for diagnostic purposes. Optiscan Imaging Ltd has a rich history of research and development, consistently striving to push the boundaries of medical imaging. With its advanced imaging solutions, Optiscan continues to contribute to the progression of healthcare.
Optiscan Imaging Ltd has achieved several significant milestones. The company successfully developed and patented a revolutionary confocal endomicroscopy technology, which enables real-time, high-resolution imaging of living tissue. Optiscan Imaging Ltd also received clearance from the U.S. Food and Drug Administration (FDA) for its confocal endomicroscopy system, facilitating its entry into the American market. Furthermore, the company collaborated with renowned medical institutions and researchers worldwide to conduct clinical studies and validate the efficacy of its imaging technology. Optiscan Imaging Ltd's relentless dedication to innovation and research has positioned it as a leader in the field of real-time tissue imaging.
Optiscan Imaging Ltd is primarily present in Australia.
Optiscan Imaging Ltd is a company known for its strong commitment to innovation and excellence in medical imaging. With a vision to improve patient outcomes, Optiscan prides itself on providing cutting-edge solutions for real-time cellular imaging. The company's corporate philosophy revolves around leveraging advanced technology to enhance diagnostic accuracy and enhance the effectiveness of medical procedures. Optiscan Imaging Ltd values integrity, collaboration, and a customer-centric approach, ensuring that their products and services meet the evolving needs of the medical community. By prioritizing research and development, Optiscan aims to revolutionize the field of medical imaging, while maintaining a steadfast dedication to quality and patient care.
Při aktuálním kurzu se akcie Optiscan Imaging obchoduje za 0,09 EUR (0,15 AUD).
Akcie Optiscan Imaging (OIL.AX) je kótována na 1 burzách, mimo jiné: ASX (OIL.AX).
Optiscan Imaging Ltd is a leading provider of high-quality microscope systems and components for scientific research, medical diagnostics, and industrial testing and quality assurance. The company was founded in Melbourne, Australia in 1994 and has since expanded its operations worldwide. Today, Optiscan Imaging is a global company that delivers innovative technologies and products to meet the needs of its customers in various industries.
Tržby za Optiscan Imaging činí 448 769,00 AUD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk za Optiscan Imaging činí -6,99 Mil. AUD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) Optiscan Imaging je aktuálně -22,42. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie Optiscan Imaging.
Poměr ceny k tržbám (P/S) Optiscan Imaging je aktuálně 349,01. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie Optiscan Imaging.
Score kvality pro Optiscan Imaging je 2/10.
ISIN Optiscan Imaging je AU000000OIL4. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN Optiscan Imaging je 932111. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker Optiscan Imaging je OIL.AX. Symbol tickeru se používá k obchodování akcií Optiscan Imaging na burze.
Optiscan Imaging akcie
Optiscan Imaging Peer Group
Optiscan Imaging Ticker
Optiscan Imaging FIGI
Všechny fundamentální údaje o Optiscan Imaging v podrobné analýze
Naše analýzy akcií společnosti Optiscan Imaging zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti Optiscan Imaging. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: